Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab with CHOP-like Chemotherapy in Young Patients with Good-Prognosis Diffuse Large B-Cell Lymphoma
NCT00064116Phase 3Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- May 2001
- Primary completion
- Dec 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of rituximab in diffuse large B-cell lymphoma (DLBCL), sponsored by Canadian Cancer Trials Group. Started May 2001; status: completed.
02
Drugs
rituximab
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT00064116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00064116.